This small, for-profit Dutch company has been a driving force behind freeing cBioPortal from Memorial Sloan Kettering, as well as continued development of the software.
Genoox, which provides data analytics for integrating genomic sequencing information into clinical workflow, said the investment was led by two Israeli VC firms.
In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.
